NCT00588406 - Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Asthma

Interventions

DRUG

Budesonide

2mg/dose by nebulizer, four doses over 3 hours

DRUG

albuterol

2.5mg/dose by nebulizer, 7 doses over 6 hours

DRUG

Ipratropium bromide

2.5 mg, one dose

DRUG

Prednisone

60mg PO

Trial Locations (3)

Jacobi Medical Center, The Bronx

Long Island Jewish Medical Center, Queens

Nassau University Medical Center, East Meadow